Form 4: Abbott Laboratories Director Nancy McKinstry Reports Stock Award and Option Grant

Director Nancy McKinstry reports the acquisition of restricted stock units and a stock option grant from Abbott Laboratories on April 25, 2025.

Summary

• On April 25, 2025, Nancy McKinstry, a director of Abbott Laboratories, reported the acquisition of 1,635 common shares through restricted stock units and a stock option grant for 1,465 shares.
• The restricted stock units were awarded under the Abbott Laboratories 2017 Incentive Stock Program and will be paid in Abbott common shares upon separation from service, death, or a change in control.
• The stock option, also granted under the 2017 Incentive Stock Program, has an exercise price of $128.4 and expires on April 24, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns director interests with shareholders.

Positives

• The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
• The stock option grant provides an incentive for the director to contribute to the company's long-term success.

Future Outlook

The document does not contain specific forward-looking statements beyond the terms of the stock option and restricted stock unit awards.

Industry Context

This filing is a routine disclosure of stock-based compensation for a company director, common in publicly traded companies to align management and shareholder interests.

Comparison to Industry Standards

• Stock option and restricted stock unit grants are standard compensation practices for directors in large, publicly traded companies like Abbott Laboratories.
• Comparable companies such as Johnson & Johnson and Pfizer also utilize similar incentive programs to reward and retain their directors and executives.
• The specific terms of the grants, such as the exercise price and vesting schedule, are generally aligned with industry benchmarks for executive compensation.

Stakeholder Impact

• The stock option and restricted stock unit grants incentivize the director to act in the best interests of the shareholders.
• The grants have a minimal direct impact on employees, customers, suppliers, and creditors.

Key Dates

Keywords

Abbott Laboratories, Director, Nancy McKinstry, Stock Options, Restricted Stock Units, Form 4, Incentive Stock Program, Beneficial Ownership